Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Astellas Pharma Inc.

    OTC: ALPMF · Real-Time Price · USD
    11.10
    0.00 (0.00%)
    At close: Aug 08, 2025, 2:03 PM

    Astellas Pharma Income Statement

    Financials in JPY. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
    Revenue
    		 1,912.3B 1,867.6B 1,772.2B 1,701.8B 1,603.7B 1,543.3B 1,523.6B 1,511.8B 1,518.6B 1,468.2B 1,406.7B 1,351.8B 1,296.2B 1,300.9B 1,285.7B 1,268.7B 1,249.5B 1,253.2B 1,265.9B 1,273.7B
    Cost of Revenue
    		 349.21B 378.22B 355.6B 347.32B 325.13B 281.54B 280.06B 268.43B 288.35B 284.99B 279.93B 279.65B 253.01B 252.42B 251.25B 248.64B 246.06B 242.83B 257.42B 265.88B
    Gross Profit
    		 1,563.1B 1,489.4B 1,416.6B 1,354.5B 1,278.5B 1,261.8B 1,243.5B 1,243.4B 1,230.3B 1,183.2B 1,126.8B 1,072.2B 1,043.2B 1,048.5B 1,034.5B 1,020.1B 1,003.5B 1,010.4B 1,008.4B 1,007.8B
    Operating Income
    		 61.15B 35.36B 170.51B 112.57B 107.7B 21.73B 64.16B 145.68B 133.03B 167.59B 185.41B 152.74B 155.69B 145.95B 139.35B 111.33B 136.05B 165.8B 168.67B 227.72B
    Interest Income
    		 4.33B 8.46B 9.64B 12.01B 11.45B 9.77B 9.77B 10.96B 8.11B 9.51B 8.75B 5.62B 6.15B 7.41B 10.05B 12.69B 11.61B 7.04B 6.47B 3.98B
    Pretax Income
    		 31.24B -75.27B 60.4B 27.18B 23.53B 21.61B 64.06B 147.53B 132.36B 169.72B 188.28B 152.74B 156.89B 148.5B 145.32B 120.92B 145.32B 170.39B 172.86B 229.06B
    Net Income
    		 50.75B -57.43B 54.75B 17.38B 12.9B 58M 33.95B 107.03B 98.72B 136.43B 148.91B 118.21B 124.08B 120.17B 119.36B 100.86B 120.59B 138.31B 139.72B 187.31B
    Selling & General & Admin
    		 843.03B 824.87B 799.06B 778.8B 740.11B 706.26B 669.78B 645.06B 630.27B 613.4B 586.29B 565.13B 548.84B 547.69B 532.69B 520.65B 504.32B 508.76B 515.36B 502.6B
    Research & Development
    		 327.65B 329.27B 324.57B 316.42B 294.19B 286.41B 278.9B 266.71B 276.13B 274.41B 266.13B 261.7B 246.01B 233.32B 231.85B 225.51B 224.49B 233.29B 230.95B 228.01B
    Other Expenses
    		 331.28B 299.91B 69.23B 37.63B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 1,502B 1,454.1B 1,246.1B 1,250.5B 1,180.1B 1,249.2B 1,188.1B 1,099.4B 1,098.7B 1,015.8B 967.72B 944.37B 912.19B 929.45B 896.17B 909.53B 867.89B 844.83B 839.25B 779.12B
    Interest Expense
    		 4.5B 8.68B 11.51B 13.78B 12.01B 9.89B 9.86B 9.1B 8.78B 7.38B 5.88B 5.63B 4.95B 4.86B 4.08B 3.1B 2.34B 2.45B 2.28B 2.64B
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 1,851.2B 1,832.3B 1,601.7B 1,597.8B 1,505.2B 1,530.8B 1,468.1B 1,367.8B 1,387.1B 1,300.8B 1,247.6B 1,224B 1,165.2B 1,181.9B 1,147.4B 1,158.2B 1,114B 1,087.7B 1,096.7B 1,045B
    Income Tax Expense
    		 -19.51B -20.55B 2.95B 7.09B 7.92B 21.56B 30.11B 40.5B 33.65B 33.29B 39.37B 34.52B 32.8B 28.33B 25.96B 20.05B 24.73B 32.09B 33.14B 41.75B
    Shares Outstanding (Basic)
    		 1.82B 1.79B 1.8B 1.8B 1.79B 1.79B 1.79B 1.79B 1.81B 1.82B 1.82B 1.83B 1.84B 1.85B 1.85B 1.85B 1.86B 1.86B 1.86B 1.86B
    Shares Outstanding (Diluted)
    		 1.82B 1.79B 1.8B 1.8B 1.79B 1.8B 1.79B 1.8B 1.81B 1.82B 1.82B 1.83B 1.84B 1.85B 1.85B 1.85B 1.86B 1.86B 1.86B 1.86B
    EPS (Basic)
    		 28.26 -32.13 30.53 9.66 7.18 0.25 18.72 58.83 53.97 74.89 81.19 63.98 66.94 64.87 64.35 54.33 64.91 74.74 75.20 100.26
    EPS (Diluted)
    		 27.53 -32.22 30.41 9.63 7.11 0.18 18.67 58.76 53.93 74.85 81.14 63.94 66.90 64.83 64.32 54.31 64.88 74.71 75.16 100.19
    EBITDA
    		 419.48B 404.06B 343.86B 295.7B 260.41B 151.25B 170.16B 238.43B 239.63B 273.66B 263.77B 228.61B 213.05B 202.06B 217.93B 189.18B 214.07B 259.57B 262.21B 317.89B
    EBIT
    		 220.35B 121.77B 67.02B 36.58B 32.84B 31.5B 73.92B 156.63B 141.14B 177.1B 194.16B 158.36B 161.84B 153.36B 149.4B 124.01B 147.66B 172.84B 175.14B 231.69B
    Depreciation & Amortization
    		 199.13B 200.09B 195.91B 184.86B 157.84B 132.21B 108.23B 92.11B 105.74B 103.8B 102.33B 98.41B 79.68B 77.16B 73.79B 72.8B 72.65B 72.19B 71.19B 67.38B

    Add to Watchlist